vs

Side-by-side financial comparison of DIGI INTERNATIONAL INC (DGII) and HARROW, INC. (HROW). Click either name above to swap in a different company.

DIGI INTERNATIONAL INC is the larger business by last-quarter revenue ($130.7M vs $89.1M, roughly 1.5× HARROW, INC.). DIGI INTERNATIONAL INC runs the higher net margin — 8.6% vs 7.4%, a 1.2% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 25.1%). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 11.5%).

Digi International, Inc. is an American Industrial Internet of Things (IIoT) technology company based in Hopkins, Minnesota. Founded in 1985, they were best known in the early 1990s as a manufacturer of multi-line serial data serial cards for PC clones, allowing these machines to run multi-line bulletin board systems (BBSes). As this market began to wind down with the rise of the internet in the late 1990s, Digi began to concentrate on network attached devices and industrial monitoring.

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

DGII vs HROW — Head-to-Head

Bigger by revenue
DGII
DGII
1.5× larger
DGII
$130.7M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+8.2% gap
HROW
33.3%
25.1%
DGII
Higher net margin
DGII
DGII
1.2% more per $
DGII
8.6%
7.4%
HROW
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
11.5%
DGII

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
DGII
DGII
HROW
HROW
Revenue
$130.7M
$89.1M
Net Profit
$11.3M
$6.6M
Gross Margin
64.0%
79.3%
Operating Margin
13.1%
17.5%
Net Margin
8.6%
7.4%
Revenue YoY
25.1%
33.3%
Net Profit YoY
7.7%
-2.2%
EPS (diluted)
$0.29
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DGII
DGII
HROW
HROW
Q1 26
$130.7M
Q4 25
$122.5M
$89.1M
Q3 25
$114.3M
$71.6M
Q2 25
$107.5M
$63.7M
Q1 25
$104.5M
$47.8M
Q4 24
$103.9M
$66.8M
Q3 24
$105.1M
$49.3M
Q2 24
$105.2M
$48.9M
Net Profit
DGII
DGII
HROW
HROW
Q1 26
$11.3M
Q4 25
$11.7M
$6.6M
Q3 25
$10.0M
$1.0M
Q2 25
$10.2M
$5.0M
Q1 25
$10.5M
$-17.8M
Q4 24
$10.1M
$6.8M
Q3 24
$11.9M
$-4.2M
Q2 24
$9.7M
$-6.5M
Gross Margin
DGII
DGII
HROW
HROW
Q1 26
64.0%
Q4 25
62.4%
79.3%
Q3 25
63.9%
75.3%
Q2 25
63.5%
74.5%
Q1 25
62.1%
67.5%
Q4 24
62.0%
78.8%
Q3 24
61.1%
75.6%
Q2 24
59.2%
74.4%
Operating Margin
DGII
DGII
HROW
HROW
Q1 26
13.1%
Q4 25
13.3%
17.5%
Q3 25
12.5%
20.6%
Q2 25
13.9%
17.9%
Q1 25
13.1%
-23.5%
Q4 24
12.9%
19.3%
Q3 24
14.2%
2.7%
Q2 24
12.3%
3.1%
Net Margin
DGII
DGII
HROW
HROW
Q1 26
8.6%
Q4 25
9.6%
7.4%
Q3 25
8.7%
1.4%
Q2 25
9.5%
7.8%
Q1 25
10.0%
-37.2%
Q4 24
9.7%
10.1%
Q3 24
11.3%
-8.6%
Q2 24
9.2%
-13.2%
EPS (diluted)
DGII
DGII
HROW
HROW
Q1 26
$0.29
Q4 25
$0.31
$0.20
Q3 25
$0.26
$0.03
Q2 25
$0.27
$0.13
Q1 25
$0.28
$-0.50
Q4 24
$0.27
$0.19
Q3 24
$0.32
$-0.12
Q2 24
$0.26
$-0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DGII
DGII
HROW
HROW
Cash + ST InvestmentsLiquidity on hand
$31.7M
$72.9M
Total DebtLower is stronger
$143.0M
$250.0M
Stockholders' EquityBook value
$666.0M
$52.4M
Total Assets
$974.2M
$399.5M
Debt / EquityLower = less leverage
0.21×
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DGII
DGII
HROW
HROW
Q1 26
$31.7M
Q4 25
$30.9M
$72.9M
Q3 25
$21.9M
$74.3M
Q2 25
$20.1M
$53.0M
Q1 25
$26.3M
$66.7M
Q4 24
$25.9M
$47.2M
Q3 24
$27.5M
$72.6M
Q2 24
$28.3M
$71.0M
Total Debt
DGII
DGII
HROW
HROW
Q1 26
$143.0M
Q4 25
$135.0M
$250.0M
Q3 25
$159.2M
$347.2M
Q2 25
$40.1M
$250.6M
Q1 25
$70.0M
$256.9M
Q4 24
$95.0M
$262.7M
Q3 24
$123.2M
$230.7M
Q2 24
$151.6M
$236.3M
Stockholders' Equity
DGII
DGII
HROW
HROW
Q1 26
$666.0M
Q4 25
$649.2M
$52.4M
Q3 25
$636.1M
$47.0M
Q2 25
$621.5M
$49.7M
Q1 25
$605.2M
$56.5M
Q4 24
$590.7M
$69.7M
Q3 24
$581.0M
$58.0M
Q2 24
$563.1M
$58.5M
Total Assets
DGII
DGII
HROW
HROW
Q1 26
$974.2M
Q4 25
$918.4M
$399.5M
Q3 25
$922.6M
$363.1M
Q2 25
$770.3M
$345.0M
Q1 25
$781.0M
$364.2M
Q4 24
$796.1M
$389.0M
Q3 24
$815.1M
$351.5M
Q2 24
$820.4M
$306.6M
Debt / Equity
DGII
DGII
HROW
HROW
Q1 26
0.21×
Q4 25
0.21×
4.77×
Q3 25
0.25×
7.39×
Q2 25
0.06×
5.05×
Q1 25
0.12×
4.55×
Q4 24
0.16×
3.77×
Q3 24
0.21×
3.98×
Q2 24
0.27×
4.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DGII
DGII
HROW
HROW
Operating Cash FlowLast quarter
$77.1M
$8.4M
Free Cash FlowOCF − Capex
$8.1M
FCF MarginFCF / Revenue
9.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
6.82×
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DGII
DGII
HROW
HROW
Q1 26
$77.1M
Q4 25
$35.6M
$8.4M
Q3 25
$28.0M
$16.6M
Q2 25
$24.0M
$-803.0K
Q1 25
$26.3M
$19.7M
Q4 24
$29.7M
$-17.8M
Q3 24
$26.4M
$3.0M
Q2 24
$24.9M
$-2.7M
Free Cash Flow
DGII
DGII
HROW
HROW
Q1 26
Q4 25
$35.2M
$8.1M
Q3 25
$27.5M
$16.4M
Q2 25
$22.9M
$-969.0K
Q1 25
$25.7M
$19.5M
Q4 24
$29.1M
$-18.3M
Q3 24
$25.5M
$2.3M
Q2 24
$24.5M
$-3.1M
FCF Margin
DGII
DGII
HROW
HROW
Q1 26
Q4 25
28.7%
9.1%
Q3 25
24.1%
22.9%
Q2 25
21.3%
-1.5%
Q1 25
24.6%
40.8%
Q4 24
28.1%
-27.4%
Q3 24
24.3%
4.8%
Q2 24
23.2%
-6.3%
Capex Intensity
DGII
DGII
HROW
HROW
Q1 26
Q4 25
0.4%
0.4%
Q3 25
0.4%
0.3%
Q2 25
0.9%
0.3%
Q1 25
0.5%
0.4%
Q4 24
0.6%
0.8%
Q3 24
0.9%
1.2%
Q2 24
0.5%
0.7%
Cash Conversion
DGII
DGII
HROW
HROW
Q1 26
6.82×
Q4 25
3.04×
1.27×
Q3 25
2.81×
16.26×
Q2 25
2.34×
-0.16×
Q1 25
2.50×
Q4 24
2.95×
-2.62×
Q3 24
2.23×
Q2 24
2.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons